Pharmaceutical Companies
Akebia Therapeutics
πΊπΈUnited States
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs...
Aldeyra Therapeutics
πΊπΈUnited States
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat...
ALTO NEUROSCIENCE, INC.
πΊπΈUnited States
- Ownership
- Public
- Established
- 2019-01-01
- Employees
- 63
- Market Cap
- $318.9M
Adaptimmune Therapeutics
π¬π§United Kingdom
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by...
MeiraGTx LLC
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $315.6M
- Website
- -
Editas Medicine
πΊπΈUnited States
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The...
PEPGEN
π¬π§United Kingdom
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $311.8M
- Website
- -
Vanda Pharmaceuticals
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 203
- Market Cap
- $311.8M
- Website
- -
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and...
JASPER THERAPEUTICS, INC
πΊπΈUnited States
ALIMERA SCIENCES INC
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $304M
- Website
- -
